Clinician-supervised metabolic program — labs included, full titration support, and ongoing care. Compound semaglutide and tirzepatide from $249/month. No prior authorization. No insurance required.
Section 1
This program is designed for people who:
This program may NOT be appropriate if:
Your clinician will make the final determination during your consultation. The criteria above are guidelines, not absolutes.
Section 2
Initial evaluation of your health history, goals, and contraindications. Monthly async check-ins to assess response and adjust your protocol.
Baseline labs ordered at start. Quarterly monitoring of relevant metabolic markers. Your clinician reviews results and adjusts accordingly.
Compound semaglutide or tirzepatide — injections or oral formulations — prescribed only if your clinician determines it's clinically appropriate.
Nutrition principles, movement guidelines, and sleep protocols tailored to support and extend GLP-1 outcomes — designed by your care team.
Monthly weight, energy, and symptom check-ins via the patient portal. Lab trends visualized over time so you can see what's working.
Unlimited asynchronous messaging with your care team. Most messages answered within 24 hours. 24/7 support line for urgent concerns.
Section 3
Glucagon-like peptide-1 (GLP-1) is a hormone naturally produced in the gut after eating. It stimulates insulin release in a glucose-dependent manner, suppresses glucagon, slows gastric emptying, and — critically — acts on brain receptors to reduce appetite and what researchers call "food noise." GLP-1 receptor agonist medications extend these effects for days rather than minutes.
The SURMOUNT-1 trial demonstrated that tirzepatide produced an average body weight reduction of 20.9% over 72 weeks. The SELECT trial (semaglutide, 2023) showed a 20% reduction in major adverse cardiovascular events independent of weight loss — establishing GLP-1 agonists as cardiovascular medications, not merely weight loss drugs.
The most common side effects are gastrointestinal: nausea, constipation, and reduced appetite. These are dose-dependent and typically diminish as the body adapts. Titrating the dose slowly — which your clinician will manage — substantially reduces the incidence and severity.
Section 4
Compound injections
from $249/mo
Compound oral formulations
from $279/mo
Branded (Ozempic / Zepbound)
from $1,299/mo
Typical program duration: 6–12 months minimum for meaningful, sustained outcomes
Your clinician will recommend a timeline based on your response and progress
Labs, clinician consultations, and support are included — no separate billing
No insurance required. Cash-pay. No prior authorizations or claim denials.
When you reach your clinical goals
Your clinician will transition you to a maintenance plan — a lower-dose or lower-frequency protocol designed to preserve your results. The goal of this program is a sustainable metabolic improvement, not indefinite medication dependency.
Ready to proceed?
Compounded Medication Disclosure
Compounded medications are prepared by a licensed compounding pharmacy and are NOT approved by the U.S. Food and Drug Administration. They are dispensed only pursuant to a prescription from a licensed clinician who has determined the treatment is appropriate for you. Not all patients will qualify. Side effects are possible; your clinician will review your health history with you. Medication options and availability may change at any time without notice. This information is educational and is not a substitute for individualized medical advice.
The Enough! Health Ecosystem
Wellness, insurance, and group coverage — separately available, designed to work together.
GLP-1 medications require a clinician assessment and prescription. Not all patients will qualify. Compound medications are not FDA-approved but are prepared by licensed pharmacies under applicable regulations. Enough! Health Wellness services are provided through our licensed clinical partner network. 18+ only.